ADNOSINE-108 Tablets
Adenosine 5-Monophosphate (AMP) 2.5mg, L-Arginine Decarboxylated 2.5mg & L-Carnosine 25.0mg
Reference MRP
₹1450.00
Standard Packaging
10 Strips x 1 x 10 Film-Coated Tablets per outer mono-carton (100 Tablets Box / Master Shipper: 40 Boxes)
ADNOSINE-108 Tablets represent an advanced therapeutic breakthrough in neurovascular microcirculation and cellular bioenergetics. Formulated by Redition Pharma under strict cleanroom GMP protocols, ADNOSINE-108 integrates pharmaceutical-grade Adenosine 5-Monophosphate (AMP), Decarboxylated L-Arginine, and L-Carnosine. AMP functions as an immediate precursor to ATP and purinergic cyclic-AMP (cAMP), restoring trans-membrane ionic gradients in ischemic and fatigued neural tissue. Decarboxylated L-Arginine selectively downregulates excitotoxic NMDA channels and enhances endothelial nitric oxide synthase (eNOS) for microvascular vasodilation. Concurrently, L-Carnosine acts as a brain-penetrating anti-glycation dipeptide that quenches toxic reactive oxygen species (ROS) and halts advanced glycation end-product (AGE) accumulation along axonal myelin sheaths.
Lic. 12116801000249Request batch Certificate of Analysis (COA), technical dossier, and institutional rate contracts.
Pharmacological Advantages & Clinical Evidence
- 01
Targeted Tri-Pathway Synergism: Re-energizes cellular ATP reserves, promotes microvascular perfusion, and arrests axonal lipid peroxidation.
- 02
Adenosine 5-Monophosphate (AMP 2.5mg): Rapidly restores high-energy purinergic phosphorylation and neuromuscular signal transduction.
- 03
Decarboxylated L-Arginine (2.5mg): Dual NMDA receptor antagonism and selective endothelial microcirculation enhancement for rapid neuropathic relief.
- 04
L-Carnosine (25.0mg): High-potency anti-glycation dipeptide protecting peripheral nerve fibers against advanced glycation end-products (AGEs).
- 05
Pharmaceutical Blister Strip Packaging: 10 x 1 x 10 film-coated tablets in individual moisture-barrier foils ensuring complete shelf-stability.
Clinical Indications
- —Diabetic Peripheral Neuropathy & Axonal Hypoperfusion
- —Cellular Mitochondrial Dysfunction & ATP Exhaustion
- —Peripheral Microvascular Insufficiency & Paresthesia (Numbness/Tingling)
- —Cerebrovascular & Neuro-Oxidative Stress Protection
- —Post-Ischemic Neuronal Recovery & Nerve Conduction Regeneration
Technical Specifications
- Active Ingredient
- Adenosine 5-Monophosphate (AMP), Decarboxylated L-Arginine (Agmatine), L-Carnosine
- Dosage Form
- Film-Coated Tablet
- Pharmacopoeial Standard
- In-House Validated Nutraceutical Monograph
- Formulation Category
- Neuro-Mitochondrial Cytoprotective & Cellular Bioenergetics Agent
- Administration
- Adults: One tablet once or twice daily after meals with water, or as directed by the prescribing physician/healthcare practitioner.
- Packaging Format
- 10 Strips x 1 x 10 Film-Coated Tablets per outer mono-carton (100 Tablets Box / Master Shipper: 40 Boxes)
- Storage & Stability
- Store in a cool, dry place. Protect from direct sunlight and moisture. Keep out of reach of children. | Shelf life: 24 Months from manufacturing date
Mechanism of Action
Adenosine 5-Monophosphate (AMP) acts at P2 purinergic receptors and serves as a direct nucleotide precursor in intracellular ATP resynthesis, correcting the energetic deficit in ischemic and hypoxic neural tissue. Decarboxylated L-Arginine binds with high affinity to alpha-2 adrenergic and imidazoline receptors while attenuating neuronal nitric oxide synthase (nNOS), resulting in reduced neuroinflammation and improved endothelial capillary microcirculation. L-Carnosine scavenges cytotoxic alpha-beta unsaturated aldehydes and hydroperoxides while preventing cross-linking of neural structural proteins.
Institutional FAQs
What is ADNOSINE-108 Tablets prescribed or recommended for?
ADNOSINE-108 Tablets is an advanced nutraceutical neurovascular formulation designed to support peripheral nerve regeneration, enhance mitochondrial ATP synthesis, and improve microvascular blood flow in conditions like diabetic neuropathy, paresthesia, and cellular metabolic exhaustion.
What is the active composition of each ADNOSINE-108 tablet?
Each film-coated tablet contains Adenosine 5-Monophosphate (AMP) 2.5 mg, Decarboxylated L-Arginine 2.5 mg, and L-Carnosine 25.0 mg, formulated with pharmaceutical-grade excipients and appropriate overages to ensure 100% active retention throughout its 24-month shelf life.
How does Adenosine 5-Monophosphate (AMP) benefit nerve health?
AMP directly participates in cellular bioenergetics by serving as a building block for ATP and cyclic AMP (cAMP). This fuels the Na+/K+-ATPase pumps essential for electrical signal conduction across nerve axons.
Is batch-specific Certificate of Analysis (COA) provided for institutional orders?
Yes. Every commercial batch of ADNOSINE-108 dispatched by Redition Pharma includes a validated Certificate of Analysis verifying assay potency, dissolution profile, and heavy metal/microbial compliance.
Procurement & Dossier Request for ADNOSINE-108 Tablets
Submit your hospital tender requirements, rate-contract bids, or Certificate of Analysis (COA) requests. Our regulatory trade desk dispatches validated batch documentation within 24 hours.
Founder & Managing Director
Nilesh Kumar
Direct Sales & Dispatch Line
+91 79877 79819Regulatory Dossiers & RFQ
reditionpharma@gmail.comRegistered Corporate Office
101, 1st Floor, Bhumi Park Society, Punagam Chorasi Bombay Market, Surat, Gujarat 395010, India